Vaginal cancer is an abnormal growth of cells in the vagina, the muscular tissue shaped like a tube that connects the uterus with the external genitals. Vaginal cancer is a rare form of cancer that usually originates in the vaginal surface, also known as the vaginal wall or birth canal. Each year, just over 4,000 cases of vaginal cancer are diagnosed. The squamous cells that make up the epithelial lining of the vagina are most susceptible to cancer.
The four primary types of vaginal cancer are categorized according to the types of cell where the cancer originates in the vagina:
Although there are no definitive causes of vaginal cancer (or most other cancers), certain risk factors suggest a correlation to increased chance of vaginal cancer. Some risk factors include:
Additionally, women with a history or uterus cancer, abnormal cells in the uterus and hysterectomy have an elevated chance of getting vaginal cancer.
Vaginal cancer typically does not present symptoms in early stages, and the cancer may be found during a pelvic or Pap smear exam. But as it develops over time symptoms that may present include:
Abnormal vaginal bleeding between periods
Vaginal cancer is screened in numerous ways. These include a pelvic exam, Pap smear, colposcopy or biopsy.
Vaginal cancer diagnoses carry a high cure rate when detected early. Treatment plans will depend on the stage of the cancer (the progression of its spread in the vagina and to other areas). Vaginal cancer diagnosed in later stages or in instances when it has spread beyond the vagina prove much more difficult to treat and cure. Treatment also depends on the cancer’s location, as well as whether the woman has had a hysterectomy or previous radiation treatments to the pelvis.
Primary treatments for vaginal cancer include surgery, radiation therapy or chemotherapy. Depending on how advanced the cancer is, treatments may be combined.
Learn about the innovative treatment options and research trials being offered at CU Anschutz.
Learn about the innovative treatment options and research trials being offered at CU Anschutz.